$129 Million is the total value of COREPATH WEALTH PARTNERS LLC's 38 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 11.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IVV | Buy | ISHARES TRcore s&p500 etf | $27,007,000 | +28.6% | 60,768 | +19.5% | 20.90% | +13.2% |
| EFA | Buy | ISHARES TRmsci eafe etf | $13,561,000 | +8.4% | 168,859 | +5.3% | 10.50% | -4.6% |
| IUSV | Buy | ISHARES TRcore s&p us vlu | $13,455,000 | +13.8% | 183,907 | +9.3% | 10.41% | +0.2% |
| AGG | Buy | ISHARES TRcore us aggbd et | $8,457,000 | +11.0% | 73,037 | +9.5% | 6.55% | -2.3% |
| IWM | Buy | ISHARES TRrussell 2000 etf | $8,088,000 | +9.8% | 36,206 | +9.4% | 6.26% | -3.3% |
| EFV | Buy | ISHARES TReafe value etf | $7,774,000 | +7.9% | 149,057 | +7.4% | 6.02% | -5.0% |
| TIP | Buy | ISHARES TRtips bd etf | $7,435,000 | +30.3% | 57,649 | +26.6% | 5.76% | +14.7% |
| LQD | Buy | ISHARES TRiboxx inv cp etf | $7,336,000 | +17.6% | 54,481 | +14.2% | 5.68% | +3.5% |
| EEM | Buy | ISHARES TRmsci emg mkt etf | $7,122,000 | +2.4% | 137,110 | +5.6% | 5.51% | -9.8% |
| ISTB | Buy | ISHARES TRcore 1 5 yr usd | $4,708,000 | +10.0% | 91,894 | +10.1% | 3.64% | -3.2% |
| IJS | Buy | ISHARES TRsp smcp600vl etf | $4,605,000 | +5.0% | 45,253 | +4.6% | 3.56% | -7.6% |
| IAGG | Buy | ISHARES TRcore intl aggr | $4,305,000 | +11.3% | 77,145 | +9.6% | 3.33% | -2.0% |
| HYG | Buy | ISHARES TRiboxx hi yd etf | $1,685,000 | +10.5% | 19,281 | +10.3% | 1.30% | -2.8% |
| VTV | Buy | VANGUARD INDEX FDSvalue etf | $1,465,000 | +8.8% | 10,449 | +3.6% | 1.13% | -4.2% |
| NVTA | Buy | INVITAE CORP | $460,000 | +27.4% | 15,500 | +63.2% | 0.36% | +12.3% |
| AOA | Buy | ISHARES TRaggres alloc etf | $399,000 | +23.1% | 5,595 | +18.3% | 0.31% | +8.4% |
| IJR | Buy | ISHARES TRcore s&p scp etf | $250,000 | +11.6% | 2,246 | +9.8% | 0.19% | -1.5% |
| AOR | New | ISHARES TRgrwt allocat etf | $242,000 | – | 4,286 | +100.0% | 0.19% | – |
| FATE | New | FATE THERAPEUTICS INC | $215,000 | – | 2,250 | +100.0% | 0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 12 | Q3 2023 | 26.4% |
| ISHARES TR | 12 | Q3 2023 | 11.0% |
| ISHARES TR | 12 | Q3 2023 | 11.5% |
| ISHARES TR | 12 | Q3 2023 | 10.8% |
| ISHARES TR | 12 | Q3 2023 | 6.5% |
| ISHARES TR EAFE VALUE ETF | 12 | Q3 2023 | 6.3% |
| ISHARES TRUST MSCI EMG MKTS ETF USD DIS | 12 | Q3 2023 | 6.6% |
| ISHARES TR | 12 | Q3 2023 | 8.1% |
| ISHARES TR | 12 | Q3 2023 | 4.7% |
| ISHARES TR | 12 | Q3 2023 | 3.9% |
View COREPATH WEALTH PARTNERS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-01-12 |
| 13F-HR | 2023-10-24 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-09 |
| 13F-HR | 2022-01-24 |
View COREPATH WEALTH PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.